The impact of metabolic changes in type 2 diabetes on bone turnover.




diabetes mellitus, insulin, bone remodeling


This article carried out analyzes which helps to identify risk factors associated with bone metabolism changes, and to determine indicators that are informative in terms of predicting the risk of low-traumatic fractures observed in patients with type 2 diabetes mellitus. This study revealed some correlation between serum insulin level, bone metabolism markers and bone mass density determined at the lumbar DXA in patients with type 2 diabetes mellitus. This suggests that the presence of type 2 diabetes in anamnesis aggravated violation of disturbances of bone remodeling, thus contributing to the development of osteoporosis. The purpose of this study was to identify complex relationships between the mineral, organic component of bone and the risk of fractures under the influence of metabolic changes associated with type 2 diabetes. This study suggests that obesity and hyperinsulinemia can not be bone-protective factors, this is confirmed by the growing body of evidence that points to the importance of measuring bone remodeling markers in combination with bone mineral density in assessing and predicting the risk of fractures. Clarification of the role of insulin in assessing bone health remains a matter of debate.

Author Biography

Sain Sattar Safarova

Azerbaijan Medical University
Department of Internal Diseases III
S. Vurgun str., 167, Baku, AZ1022, Azerbaijan


Farr JN, Khosla S. Determinants of bone strength and quality in diabetes mellitus in humans. Bone. 2016;82:28-34.

Kahn SE. The relative contributions of insulin re­sistance and β–cell dysfunction to the patophysiology of type 2 diabetes. Diabetologia. 2005;48:3-19.

Premaor MO, Comim FV, Compston JE. Obesity and fractures. Arq Bras Endocrinol Metabol. 2014;58:470-7.

Hewston P, Deshpande N. Falls and balance impair­ments in older adults with type 2 diabetes: thinking beyond diabetic peripheral neuropathy. Can. J.Diabetes. 2016;40:6-9.

Riddle RC, Clemens TL. Insulin, osteoblasts, and energy metabolism: why bone counts calories. J Clin Invest. 2014;124:1465-7.

Manavalan JS, et al. Circulating osteogenic pre­cursor cells in type 2 diabetes mellitus. J. Clin. Endo­crinol. Metab. 2012;97:3240-50.

Pramojanee SN, Phimphilai M, Chattipakorn N, Chattipakorn SC. Possible roles of insulin signaling in osteoblasts. Endocrine Research. 2014;39(4):144-51.

Bredella MA, Gill CM, Gerweck AV, Landa MG, Kumar V, Daley SM, et al. Ectopic and serum lipid levels are positively associated with bone marrow fat in obesity. Radiology. 2013;269:534-41.

Russell M, Mendes N, Miller KK, Rosen CJ, Lee H, Klibanski A, et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010;95:1247-55.

Starup-Linde J, Vestergaard P. Biochemical bone turnover markers in diabetes mellitus – a systematic review. Bone. 2016;82:69-78.


How to Cite

Safarova SS. The impact of metabolic changes in type 2 diabetes on bone turnover. Med. perspekt. [Internet]. 2018Jun.25 [cited 2024Jun.19];23(2):143-7. Available from: